Lorviqua

Lorviqua (lorlatinib) is an oral medication used to treat certain types of cancer. This advanced therapy targets specific proteins to help manage disease progression.

Lorviqua is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic markers. It works by targeting proteins involved in cancer cell growth, making it a targeted therapy option. Patients often wonder, 'What is Lorviqua used for?'—it is designed for those who have progressed on other treatments.

Common effects of Lorviqua may include fatigue, nausea, and swelling. Some users also report changes in mood or appetite. These effects can vary widely among individuals.

Lorviqua should be handled with care, stored as directed, and taken exactly as prescribed. It is important to discuss any pre-existing conditions or allergies with a healthcare provider before starting this medication.

Lorviqua may interact with certain medications, including those metabolized by the liver. Alcohol and other substances that affect liver enzymes could potentially alter its effectiveness. Always inform your healthcare provider about all medications you are taking.